Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ClearPoint Neuro, Inc.Financial_Report.xls
10-Q - FORM 10-Q - ClearPoint Neuro, Inc.mrii20130930_10q.htm
EX-31 - EXHIBIT 31.2 - ClearPoint Neuro, Inc.ex31-2.htm
EX-31 - EXHIBIT 31.1 - ClearPoint Neuro, Inc.ex31-1.htm

Exhibit 32

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER

THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF

CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE

 

 

 

Each of the undersigned, Kimble L. Jenkins and David W. Carlson, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended September 30, 2013, of MRI Interventions, Inc. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 13, 2013

 

 

 

/s/ Kimble L. Jenkins

 

Kimble L. Jenkins

 

Chief Executive Officer

   
   
   
 

/s/ David W. Carlson

 

David W. Carlson

 

Chief Financial Officer